Home Diagnostics Growth Athelas's home diagnostics push with Athelas Home enables at-home blood testing and remote data capture; ideal for partnerships with primary care networks, home health providers, and chronic-care programs to drive new revenue through integrated diagnostics, EHR data, and RCM touchpoints.

Interoperability Advantage Acquiring Commure signals a strategic focus on platform interoperability across RCM, EHR, and remote patient monitoring; use this to pitch a unified, multi-vendor consolidation solution to health systems seeking streamlined workflows and faster time-to-value.

Enterprise Adoption A strong installed base and sizable revenue position Athelas to pursue mid-market and enterprise health systems; cross-sell AI-driven RCM, ambient AI, and EHR enhancements to expand footprint within existing provider networks.

AI Efficiency AI-driven RCM and ambient AI capabilities promise measurable ROI by reducing manual tasks, speeding billings, and lowering denials; tailor messaging to CFOs and operations leaders evaluating scalable automation across clinics.

Partnership Momentum Past collaborations with family medicine and RPM initiatives show appetite for remote monitoring programs; target ACOs, payer networks, and clinic groups to scale RPM, diagnostics, and automated revenue workflows through joint go-to-market.